JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumab.
Saved in:
| Title: | JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumab. |
|---|---|
| Authors: | Wu Q; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, United States.; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI, United States., Mills EA; Alzheimer's Drug Discovery Foundation, New York, NY, United States., Wang Q; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI, United States., Mao G; School of Public Health, University of Michigan, Ann Arbor, MI, United States., Mao-Draayer Y; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI, United States.; Autoimmunity Center of Excellence, Multiple Sclerosis Center of Excellence, Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States. |
| Source: | Frontiers in neurology [Front Neurol] 2025 Aug 04; Vol. 16, pp. 1584083. Date of Electronic Publication: 2025 Aug 04 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2295 |
|---|---|
| DOI: | 10.3389/fneur.2025.1584083 |
